Xtant Medical Holdings, Inc. (XTNT) is a publicly traded Healthcare sector company. As of May 21, 2026, XTNT trades at $0.46 with a market cap of $63.96M and a P/E ratio of 11.70. XTNT moved +1.33% today. Year to date, XTNT is -38.55%; over the trailing twelve months it is -35.80%. Its 52-week range spans $0.33 to $0.95. Analyst consensus is strong buy with an average price target of $1.25. Rallies surfaces XTNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Xtant Medical Holdings, Inc. (XTNT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. XTNT moved +1.33% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $0.46 |
| Market Cap | $63.96M |
| P/E Ratio | 11.70 |
| EPS | $0.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.95 |
| 52-Week Low | $0.33 |
| Volume | 303.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $133.93M |
| Net Income | $4.97M |
| Gross Margin | 62.92% |
3 analysts cover XTNT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1.25.